Cargando…
Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition
KRAS, an oncogene, is frequently activated by mutations in many cancers. Kras-driven adenocarcinoma development in the lung, pancreas, and biliary tract has been extensively studied using gene targeting in mice. By taking the organoid- and allograft-based genetic approach to these organs, essentiall...
Autores principales: | Maru, Yoshiaki, Tanaka, Naotake, Tatsumi, Yasutoshi, Nakamura, Yuki, Itami, Makiko, Hippo, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233399/ https://www.ncbi.nlm.nih.gov/pubmed/34172714 http://dx.doi.org/10.1038/s41389-021-00337-8 |
Ejemplares similares
-
Establishment and characterization of patient‐derived organoids from a young patient with cervical clear cell carcinoma
por: Maru, Yoshiaki, et al.
Publicado: (2019) -
Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021) -
Derivation of pancreatic acinar cell carcinoma cell line HS‐1 as a patient‐derived tumor organoid
por: Hoshi, Daisuke, et al.
Publicado: (2022) -
Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives
por: Maru, Yoshiaki, et al.
Publicado: (2021) -
Shortcuts to intestinal carcinogenesis by genetic engineering in organoids
por: Maru, Yoshiaki, et al.
Publicado: (2019)